Who
Karen Drexler
Director
Company insider
Files Form 4 as: Director, Outset Medical; Director, EBR Systems; Director, ResMed; Director, Valion Bio; Director, Diadexus; Director, diaDexus, Inc. (pre-merger).
In numbers
- Trades disclosed
- 45
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $233K
- Companies
- 6
- Companies where not an officer
- 6
- First trade
- 4 Nov 2010
- Last trade
- 4 Jun 2026
- Last filed
- 28 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Jun 2026filed 5 Jun 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Code A | —10,667 at $0.00 | filing |
| 4 Jun 2026filed 5 Jun 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Code A | —10,667 at $0.00 | filing |
| 6 May 2026filed 28 Jul 2026 | EBR Systemsoption or derivative | SEC FORM 4 Code A | —34,211 at $0.00 | filing |
| 6 May 2026filed 8 May 2026 | EBR Systemsoption or derivative | SEC FORM 4 Code A | —34,211 at $0.00 | filing |
| 1 Dec 2025filed 2 Dec 2025 | OM Outset MedicalMedical Devices | SEC FORM 4 Sold | $6,7651,548 at $4.37 | filing |
| 20 Nov 2025filed 24 Nov 2025 | RMD ResMedMedical Devices | SEC FORM 4 Code A | —1,073 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | OM Outset MedicalMedical Devices | SEC FORM 4 Code A | —8,983 at $0.00 | filing |
| 21 May 2025filed 22 May 2025 | EBR Systemsoption or derivative | SEC FORM 4 Code A | —175,781 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | OM Outset Medicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —125 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | OM Outset MedicalMedical Devices | SEC FORM 4 Code M | —31,250 | filing |
| 7 Mar 2025filed 11 Mar 2025 | OM Outset Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | $25K125 at $200.00 | filing |
| 20 Nov 2024filed 22 Nov 2024 | RMD ResMedMedical Devices | SEC FORM 4 Code A | —1,083 at $0.00 | filing |
| 9 Aug 2024filed 13 Aug 2024 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —3,000 at $0.00 | filing |
| 29 May 2024filed 29 May 2024 | OM Outset MedicalMedical Devices | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 29 Apr 2024filed 30 Apr 2024 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $91K425 at $214.92 | filing |
| 16 Nov 2023filed 20 Nov 2023 | RMD ResMedoption or derivative · Medical Devices | SEC FORM 4 Code A | $383K2,575 at $148.90 | filing |
| 16 Nov 2023filed 20 Nov 2023 | RMD ResMedMedical Devices | SEC FORM 4 Code A | —884 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 31 May 2023filed 31 May 2023 | OM Outset MedicalMedical Devices | SEC FORM 4 Code A | —7,681 at $0.00 | filing |
| 2 Feb 2023filed 3 Feb 2023 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $135K594 at $226.58 | filing |
News
Outset Medical (NASDAQ:OM) vs. InspireMD (NYSE:NSPR) Financial ComparisonOM · tickerreport.com · 21 Oct 2026Head-To-Head Contrast: Femasys (NASDAQ:FEMY) versus Outset Medical (NASDAQ:OM)OM · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Karen Drexler; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.